Lily Chu

Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine. In addition to treating ME/CFS, she is a ME/CFS patient.

She is currently the Co-Vice president of the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

She is a member of the ME/CFS Advisory Board for Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Initiative.

She was one of the panel members of the 2015 Institute of Medicine report: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.

Open Letter to The Lancet
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

Quotes

 * 2016 - "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."

Talks and Interviews

 * 2015, Solve CFS Webinar - Post-Exertional Malaise: History, Characteristics, Evidence

Reports and/or Articles

 * May2016, Suicide and ME/CFS --Lily Chu, MD, MSHS

HHS/CFSAC Testimony

 * CFSAC Public Testimony December 2014
 * Written Testimony for June 2012 meeting
 * Written Testimony for Nov 2011 meeting
 * Written Testimony for May 2011 meeting
 * Written Testimony for October 2009 meeting